Search Within

Eileen O'Reilly

Formats
  1. Meeting Abstract (370)
  2. Journal Article (365)
  3. Review (24)
  4. Book Section (9)
  5. Correspondence (9)
  6. Editorial (8)
  7. Conference Paper (5)
  8. Miscellaneous (5)
  9. Book Whole (4)
  10. Guidelines (3)
  11. Research Letter (1)
Groups
  1. Center for Pancreatic Cancer Research (803)
  2. Department of Medicine (803)
  3. Gastrointestinal Oncology Service (803)
  4. Solid Tumor Oncology Division (803)
  5. Epidemiology and Biostatistics (184)
  6. Surgery (173)

More Groups

People
  1. Ghassan Abou-Alfa (160)
  2. Kenneth Yu (123)
  3. David Kelsen (112)
  4. Maeve Lowery (99)
  5. Marinela Capanu (97)
  6. William Jarnagin (88)

More People

Years
  1. 2025 (50)
  2. 2024 (76)
  3. 2023 (73)
  4. 2022 (57)
  5. 2021 (54)
  6. 2020 (70)

More Years

Publications
  1. Journal of Clinical Oncology (296)
  2. Annals of Oncology (51)
  3. Cancer (28)
  4. Annals of Surgical Oncology (26)
  5. Clinical Cancer Research (23)
  6. Gastrointestinal Cancer Research (18)

More Publications

Publishers
  1. American Society of Clinical Oncology (312)
  2. Oxford University Press (75)
  3. Elsevier Inc. (49)
  4. Springer (47)
  5. Wiley Blackwell (43)
  6. American Association for Cancer Research (40)

More Publishers

Results (803)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Phase 1 dose-escalation study of 17-allylamino-17-demethoxygeldanamycin (17AAG) in combination with irinotecan in patients with solid tumors
    Meeting Abstract

    Tse, A. N.; Carvajal, R.; Shah, M.; Dials, H.; Fogel, M.; O'Reilly, E.; Chung, K.; Maki, R.; Wu, N.; Egorin, M.; more...
    Journal of Clinical Oncology (2007)

    Fulltext@MSK | Save
  • Phase III study of gemcitabine [G] plus cetuximab [C] versus gemcitabine in patients [pts] with locally advanced or metastatic pancreatic adenocarcinoma [Pca]: SWOG S0205 study
    Meeting Abstract

    Philip, P. A.; Benedetti, J.; Fenoglio-Preiser, C.; Zalupski, M.; Lenz, H.; O'Reilly, E.; Wong, R.; Atkins, J.; Abruzzese, J.; Blanke, C.
    Journal of Clinical Oncology (2007)

    Fulltext@MSK | Save
  • Prognostic factors (PF) in advanced hepatocellular carcinoma (AHCC): Multivariate analysis and comparison between staging systems (SS) in patients (pts) treated at Memorial Sloan-Kettering Cancer Center (MSKCC)
    Meeting Abstract

    Huitzil, F. D.; Capanu, M.; Jacobs, G.; Smith, W.; O'Reilly, E.; Shah, M.; Schwartz, G. K.; Saltz, L. B.; Kelsen, D. P.; Abou-Alfa, G. K.
    Journal of Clinical Oncology (2007)

    Fulltext@MSK | Save
  • Gallbladder cancer (GBC): 10-year experience at Memorial Sloan-Kettering Cancer Centre (MSKCC)
    Meeting Abstract

    Duffy, A.; Capanu, M.; Abou-Alfa, G. K.; Huitzel, D.; Williams, P.; Jarnagin, W.; Fong, Y.; Kelsen, D. P.; O'Reilly, E. M.
    Journal of Clinical Oncology (2007)

    Fulltext@MSK | Save
  • Cytotoxic therapy for advanced pancreatic adenocarcinoma
    Journal Article

    O'Reilly, E. M.; Abou-Alfa, G. K.
    Seminars in Oncology (2007)

    Fulltext@MSK | Save
  • Phase I dose-finding study of weekly docetaxel followed by flavopiridol for patients with advanced solid tumors
    Journal Article

    Fornier, M. N.; Rathkopf, D.; Shah, M.; Patil, S.; O'reilly, E.; Tse, A. N.; Hudis, C.; Lefkowitz, R.; Kelsen, D. P.; Schwartz, G. K.
    Clinical Cancer Research (2007)

    Fulltext@MSK | Save
  • Key challenges in managing advanced pancreatic cancer - The Wisinski/Wahl/Small et al article reviewed [Inoperable pancreatic cancer: Standard of care]
    Journal Article

    Duffy, A.; O'Reilly, E. M.
    Oncology (Norwalk) (2007)

    Fulltext@MSK | Save
  • Phase I trial of preoperative cetuximab with concurrent continuous infusion 5-fluorouracil and pelvic radiation in patients with local-regionally advanced rectal cancer
    Meeting Abstract

    Chung, K. Y.; Minsky, B.; Schrag, D.; O'reilly, E.; D'adamo, D.; Hollywood, E.; Quinones, M.; Saltz, L.
    Journal of Clinical Oncology (2006)

    Fulltext@MSK | Save
  • Multicenter phase II study of irinotecan, cisplatin, and bevacizumab in patients with metastatic gastric or gastroesophageal junction adenocarcinorna
    Journal Article

    Shah, M. A.; Ramanathan, R. K.; Ilson, D. H.; Levnor, A.; D'adamo, D.; O'reilly, E.; Tse, A.; Trocola, R.; Schwartz, L.; Capanu, M.; more...
    Journal of Clinical Oncology (2006)

    Fulltext@MSK | Save
  • Randomized phase III study of exatecan and gemcitabine compared with gemcitabine alone in untreated advanced pancreatic cancer
    Journal Article

    Abou-Alfa, G. K.; Letourneau, R.; Harker, G.; Modiano, M.; Hurwitz, H.; Tchekmedyian, N. S.; Feit, K.; Ackerman, J.; De Jager, R. L.; Eckhardt, S. G.; more...
    Journal of Clinical Oncology (2006)

    Fulltext@MSK | Save